{
  "ticker": "GLO",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972385",
  "id": "02972385",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250724",
  "time": "1458",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m3gjp5cl5l59.pdf",
  "summary": "### Summary of ASX Announcement (Barrow Hanley Global Share Active ETF - ASX: GLOB)  \n\n#### **Key Fund Details**  \n- **Investment Objective**: Long-term capital growth via global equities.  \n- **Benchmark**: MSCI World Net Total Return Index ($A).  \n- **Management Fee**: 0.99%.  \n- **Top 5 Holdings**: Merck & Co. (2.9%), Bank of Nova Scotia (2.9%), Sanofi SA (2.7%), Rheinmetall AG (2.5%), Standard Chartered PLC (2.4%).  \n- **Regional Exposure**: North America (53.9%), Europe ex-UK (19.1%), UK (7.7%), Asia ex-Japan (5.4%).  \n\n#### **Performance (30 June 2025)**  \n- **1-Year Return**: 21.79% (Fund) vs. 18.48% (Benchmark).  \n- **3-Year p.a.**: 15.58% (Fund) vs. 20.22% (Benchmark).  \n- **Since Inception p.a.**: 14.53% (Fund) vs. 18.13% (Benchmark).  \n- **Latest Quarter**: +1.7% (Fund) vs. +5.9% (MSCI World Index).  \n\n#### **Portfolio Commentary Highlights**  \n- **Outperformers**: BAE Systems (defense sector resilience), Microchip Technology (semiconductor recovery).  \n- **Underperformers**: Halliburton (oil price volatility), Merck & Co. (China sales decline).  \n\n#### **Market Outlook**  \n- Narrow market leadership (AI/tech dominance) with value stocks lagging.  \n- Geopolitical and trade uncertainties persist, but fiscal stimulus and rate cuts may favor value rebound.  \n\n**No material capital markets announcements (e.g., raising, corporate action) identified.**",
  "usage": {
    "prompt_tokens": 2561,
    "completion_tokens": 397,
    "total_tokens": 2958,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T05:22:49.299405"
}